Does it excite you to build and lead an in vitro pharmacology/biology capability that accelerates drug discovery, and do you have experience developing robust, automation-ready assays to screen compounds and elucidate mechanism of action across multiple programs? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As Team Lead/Associate Director in In Vitro Pharmacology/Biology, this role will build and lead a high-performing team delivering fit-for-purpose assays to support discovery and preclinical candidate selection. The position will set scientific direction for biochemical, biophysical, and functional assay strategies, ensuring rigorous data generation and interpretation. Close cross-functional collaboration with Global Biology, Chemistry, in vivo Pharmacology, DMPK/Safety, and Formulation will be essential to deliver candidates with the desired pharmacological properties. The role will also help advance innovative platforms (e.g., automation, HTS, imaging) to increase quality, speed, and scalability.
We offer exciting responsibilities:
Your profile
This role suits a collaborative, structured, and scientifically curious leader with a strong quality mindset and the ability to balance strategic direction with practical execution. Success requires the ability to develop people, create clarity in complex portfolios, and foster an inclusive, high-performance team culture. Strong stakeholder management skills and the ability to communicate clearly with both technical and executive audiences are important.
Your new team
You will join the Global Biology research organization and work at the interface of discovery and preclinical candidate delivery. The team collaborates closely with functional experts across Chemistry, in vivo Pharmacology, DMPK/Safety, and Formulation, contributing to a portfolio of programs through robust in vitro data generation and interpretation.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Interested in bonding with us? Then please apply no later than April 25th, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
The anticipated base pay range for this position is : $173,000 - $211,000
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com
#LI-Onsite
At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other.
Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases.
Our leading obesity programs are backed by strong partners, including Roche and Boehringer Ingelheim.
We are based in Copenhagen (Søborg), Denmark, with a team in the U.S. For further information about our business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.
